Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Clinical trial NCT05549401 · COMPLETED

Trial details

NCT number: NCT05549401
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2022-09-29
Primary completion: 2022-11-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.